Vanare S, Singh R, Chen J, Kong F
Foods. 2025; 14(5).
PMID: 40077534
PMC: 11898448.
DOI: 10.3390/foods14050831.
Zandifar A, Badrfam R, Mohammaditabar M, Kargar B, Goodarzi S, Hajialigol A
Brain Behav. 2025; 15(3):e70401.
PMID: 40038860
PMC: 11879892.
DOI: 10.1002/brb3.70401.
Liu J, Tan C, Luo L, Yin X
J Alzheimers Dis Rep. 2025; 9:25424823241310719.
PMID: 40034528
PMC: 11864269.
DOI: 10.1177/25424823241310719.
Tripathi S, Kaushik M, Dwivedi R, Tiwari P, Tripathi M, Dada R
J Alzheimers Dis Rep. 2025; 8(1):1422-1433.
PMID: 40034358
PMC: 11863739.
DOI: 10.1177/25424823241289039.
Mahamud A, Tanvir I, Kabir M, Samonty I, Chowdhury M, Rahman M
Probiotics Antimicrob Proteins. 2025; .
PMID: 40029460
DOI: 10.1007/s12602-025-10501-w.
Exploring the microbiota-gut-brain axis: impact on brain structure and function.
Yassin L, Nakhal M, Alderei A, Almehairbi A, Mydeen A, Akour A
Front Neuroanat. 2025; 19:1504065.
PMID: 40012737
PMC: 11860919.
DOI: 10.3389/fnana.2025.1504065.
Neuro-Nutrition and Exercise Synergy: Exploring the Bioengineering of Cognitive Enhancement and Mental Health Optimization.
Clemente-Suarez V, Martin-Rodriguez A, Curiel-Regueros A, Rubio-Zarapuz A, Tornero-Aguilera J
Bioengineering (Basel). 2025; 12(2).
PMID: 40001727
PMC: 11851474.
DOI: 10.3390/bioengineering12020208.
Evaluating the Efficacy of Secondary Metabolites in Antibiotic-Induced Dysbiosis: A Narrative Review of Preclinical Studies.
Andrei C, Zanfirescu A, Ormeneanu V, Negres S
Antibiotics (Basel). 2025; 14(2).
PMID: 40001382
PMC: 11852119.
DOI: 10.3390/antibiotics14020138.
Gut microbiota: A new window for the prevention and treatment of neuropsychiatric disease.
Tang Y, Zhang Y, Chen C, Cao Y, Wang Q, Tang C
J Cent Nerv Syst Dis. 2025; 17:11795735251322450.
PMID: 39989718
PMC: 11846125.
DOI: 10.1177/11795735251322450.
Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease.
Abdelhamid M, Counts S, Zhou C, Hida H, Kim J, Michikawa M
Nutrients. 2025; 17(3).
PMID: 39940416
PMC: 11820889.
DOI: 10.3390/nu17030558.
Non-Drug and Non-Invasive Therapeutic Options in Alzheimer's Disease.
Sovrea A, Bosca A, Dronca E, Constantin A, Crintea A, Sufletel R
Biomedicines. 2025; 13(1).
PMID: 39857667
PMC: 11760896.
DOI: 10.3390/biomedicines13010084.
Mechanism of Action and Beneficial Effects of Probiotics in Amateur and Professional Athletes.
Nami Y, Barghi A, Shahgolzari M, Salehian M, Haghshenas B
Food Sci Nutr. 2025; 13(1):e4658.
PMID: 39803224
PMC: 11717059.
DOI: 10.1002/fsn3.4658.
Importance of Gut Microbiota Dysbiosis and Circadian Disruption-Associated Biomarkers in Emergence of Alzheimer's Disease.
Kaur S, Kumari D, Dandekar M
Mol Neurobiol. 2025; .
PMID: 39775480
DOI: 10.1007/s12035-024-04685-5.
Radiation-Induced Brain Injury: Mechanistic Insights and the Promise of Gut-Brain Axis Therapies.
Li M, Tong F, Wu B, Dong X
Brain Sci. 2025; 14(12.
PMID: 39766494
PMC: 11674909.
DOI: 10.3390/brainsci14121295.
Dietary Strategies to Mitigate Alzheimer's Disease: Insights into Antioxidant Vitamin Intake and Supplementation with Microbiota-Gut-Brain Axis Cross-Talk.
Wan Ngah W, Ahmad H, Ankasha S, Makpol S, Tooyama I
Antioxidants (Basel). 2025; 13(12.
PMID: 39765832
PMC: 11673287.
DOI: 10.3390/antiox13121504.
Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer's Disease research.
Wang H, Shi C, Jiang L, Liu X, Tang R, Tang M
Front Aging Neurosci. 2024; 16:1485657.
PMID: 39691161
PMC: 11649678.
DOI: 10.3389/fnagi.2024.1485657.
Effects of Probiotics on Neurodegenerative Disease-Related Symptoms and Systemic Inflammation: A Systematic Review.
Zhu F, Yin S, Wang Y, Zhong Y, Ji Q, Wu J
Int J Gen Med. 2024; 17:5941-5958.
PMID: 39678681
PMC: 11645901.
DOI: 10.2147/IJGM.S499406.
Implications of the Gut Microbiome in Alzheimer's Disease: A Narrative Review.
Mroke P, Goit R, Rizwan M, Tariq S, Rizwan A, Umer M
Cureus. 2024; 16(11):e73681.
PMID: 39677207
PMC: 11646158.
DOI: 10.7759/cureus.73681.
Probiotics as Potential Treatments for Neurodegenerative Diseases: a Review of the Evidence from to Clinical Trial.
Kim J, Choi Y, Lee S, Oh M
Biomol Ther (Seoul). 2024; 33(1):54-74.
PMID: 39676295
PMC: 11704393.
DOI: 10.4062/biomolther.2024.215.
Exploring the potential of probiotics in Alzheimer's disease and gut dysbiosis.
S S, L S D, Rajendran P, N H, S A
IBRO Neurosci Rep. 2024; 17:441-455.
PMID: 39629018
PMC: 11612366.
DOI: 10.1016/j.ibneur.2024.11.004.